New drug NTR-1011 tested for autoimmune diseases
Disease control
Recruiting now
This early-stage trial tested the safety of a new drug called NTR-1011 in 36 healthy adults and people with lupus or rheumatoid arthritis. The study aimed to find a safe dose and see how the drug behaves in the body. It is a first step toward possibly developing a new treatment f…
Phase: PHASE1 • Sponsor: Neutrolis • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC